315 related articles for article (PubMed ID: 23412501)
1. ING1 and ING2: multifaceted tumor suppressor genes.
Guérillon C; Larrieu D; Pedeux R
Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
[TBL] [Abstract][Full Text] [Related]
2. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
3. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.
Doyon Y; Cayrou C; Ullah M; Landry AJ; Côté V; Selleck W; Lane WS; Tan S; Yang XJ; Côté J
Mol Cell; 2006 Jan; 21(1):51-64. PubMed ID: 16387653
[TBL] [Abstract][Full Text] [Related]
4. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
5. The ING tumor suppressors in cellular senescence and chromatin.
Ludwig S; Klitzsch A; Baniahmad A
Cell Biosci; 2011 Jul; 1(1):25. PubMed ID: 21767350
[TBL] [Abstract][Full Text] [Related]
6. ING2 controls the G1 to S-phase transition by regulating p21 expression.
Larrieu D; Ythier D; Brambilla C; Pedeux R
Cell Cycle; 2010 Oct; 9(19):3984-90. PubMed ID: 20890119
[TBL] [Abstract][Full Text] [Related]
7. Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor.
Peña PV; Hom RA; Hung T; Lin H; Kuo AJ; Wong RP; Subach OM; Champagne KS; Zhao R; Verkhusha VV; Li G; Gozani O; Kutateladze TG
J Mol Biol; 2008 Jul; 380(2):303-12. PubMed ID: 18533182
[TBL] [Abstract][Full Text] [Related]
8. The new tumor suppressor genes ING: genomic structure and status in cancer.
Ythier D; Larrieu D; Brambilla C; Brambilla E; Pedeux R
Int J Cancer; 2008 Oct; 123(7):1483-90. PubMed ID: 18636562
[TBL] [Abstract][Full Text] [Related]
9. Multiple ING1 and ING2 genes in Xenopus laevis and evidence for differential association of thyroid hormone receptors and ING proteins to their promoters.
Wagner MJ; Helbing CC
Biochim Biophys Acta; 2008 Mar; 1779(3):152-63. PubMed ID: 18167318
[TBL] [Abstract][Full Text] [Related]
10. Newly identified tumor suppressor functions of ING proteins.
Heliez L; Ricordel C; Becuwe P; Pedeux R
Curr Opin Pharmacol; 2023 Feb; 68():102324. PubMed ID: 36521226
[TBL] [Abstract][Full Text] [Related]
11. ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells.
Sarker KP; Kataoka H; Chan A; Netherton SJ; Pot I; Huynh MA; Feng X; Bonni A; Riabowol K; Bonni S
J Biol Chem; 2008 May; 283(19):13269-79. PubMed ID: 18334480
[TBL] [Abstract][Full Text] [Related]
12. Domain recognition of the ING1 tumor suppressor by a panel of monoclonal antibodies.
Suzuki K; Boland D; Gong W; Riabowol K
Hybridoma (Larchmt); 2011 Jun; 30(3):239-45. PubMed ID: 21707358
[TBL] [Abstract][Full Text] [Related]
13. The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination.
Thalappilly S; Feng X; Pastyryeva S; Suzuki K; Muruve D; Larocque D; Richard S; Truss M; von Deimling A; Riabowol K; Tallen G
PLoS One; 2011; 6(6):e21065. PubMed ID: 21731648
[TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomas.
Saito M; Kumamoto K; Robles AI; Horikawa I; Furusato B; Okamura S; Goto A; Yamashita T; Nagashima M; Lee TL; Baxendale VJ; Rennert OM; Takenoshita S; Yokota J; Sesterhenn IA; Trivers GE; Hussain SP; Harris CC
PLoS One; 2010 Nov; 5(11):e15541. PubMed ID: 21124965
[TBL] [Abstract][Full Text] [Related]
15. The ING tumor suppressor genes: status in human tumors.
Guérillon C; Bigot N; Pedeux R
Cancer Lett; 2014 Apr; 345(1):1-16. PubMed ID: 24333729
[TBL] [Abstract][Full Text] [Related]
16. Phylogenetic analysis of the ING family of PHD finger proteins.
He GH; Helbing CC; Wagner MJ; Sensen CW; Riabowol K
Mol Biol Evol; 2005 Jan; 22(1):104-16. PubMed ID: 15356280
[TBL] [Abstract][Full Text] [Related]
17. ING2 controls the progression of DNA replication forks to maintain genome stability.
Larrieu D; Ythier D; Binet R; Brambilla C; Brambilla E; Sengupta S; Pedeux R
EMBO Rep; 2009 Oct; 10(10):1168-74. PubMed ID: 19730436
[TBL] [Abstract][Full Text] [Related]
18. ING2, a tumor associated gene, enhances PAI‑1 and HSPA1A expression with HDAC1 and mSin3A through the PHD domain and C‑terminal.
Ohkouchi C; Kumamoto K; Saito M; Ishigame T; Suzuki SI; Takenoshita S; Harris CC
Mol Med Rep; 2017 Nov; 16(5):7367-7374. PubMed ID: 28944862
[TBL] [Abstract][Full Text] [Related]
19. Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis.
Coles AH; Liang H; Zhu Z; Marfella CG; Kang J; Imbalzano AN; Jones SN
Cancer Res; 2007 Mar; 67(5):2054-61. PubMed ID: 17332334
[TBL] [Abstract][Full Text] [Related]
20. Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4.
Palacios A; Garcia P; Padró D; López-Hernández E; Martín I; Blanco FJ
FEBS Lett; 2006 Dec; 580(30):6903-8. PubMed ID: 17157298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
